The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients

This publication has 56 references indexed in Scilit:

• Human haematopoietic stem cell lineage commitment is a continuous process
  Nature Cell Biology, 2017
• Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment
  Cancer Cell, 2017
• Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
  Science, 2016
• Estimating T-cell repertoire diversity: limitations of classical estimators and a new approach
  Philosophical Transactions of the Royal Society B: Biological Sciences, 2015
• Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
  Clinical Cancer Research, 2015
• Tumor‐specific CD4⁺T cells maintain effector and memory tumor‐specific CD8⁺T cells
  European Journal of Immunology, 2013
• B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
  Clinical Cancer Research, 2013
• GAMMA-RADIATION UPREGULATES MHC CLASS I/II AND ICAM-I MOLECULES IN MULTIPLE MYELOMA CELL LINES AND PRIMARY TUMORS
  In Vitro Cellular & Developmental Biology - Animal, 2006
• Dysfunctional T regulatory cells in multiple myeloma
  Blood, 2006
• Relationship between CD4+/CD8+ T cell ratio and T cell activation in multiple myeloma: reference to IL-16
  Leukemia Research, 2002